| Online-Ressource |
Verfasst von: | Doll, Sophia [VerfasserIn]  |
| Kriegmair, Maximilian [VerfasserIn]  |
| Porubský, Štefan [VerfasserIn]  |
| Nuhn, Philipp [VerfasserIn]  |
Titel: | Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient |
Verf.angabe: | Sophia Doll, Maximilian C. Kriegmair, Alberto Santos, Michael Wierer, Fabian Coscia, Helen Michele Neil, Stefan Porubsky, Philipp E. Geyer, Andreas Mund, Philipp Nuhn and Matthias Mann |
E-Jahr: | 2018 |
Jahr: | 14 June 2018 |
Umfang: | 12 S. |
Fussnoten: | Gesehen am 10.04.2019 |
Titel Quelle: | Enthalten in: Molecular oncology |
Ort Quelle: | Hoboken, NJ : John Wiley & Sons, Inc., 2007 |
Jahr Quelle: | 2018 |
Band/Heft Quelle: | 12(2018), 8, Seite 1296-1307 |
ISSN Quelle: | 1878-0261 |
Abstract: | Recent advances in mass spectrometry (MS)-based technologies are now set to transform translational cancer proteomics from an idea to a practice. Here, we present a robust proteomic workflow for the analysis of clinically relevant human cancer tissues that allows quantitation of thousands of tumor proteins in several hours of measuring time and a total turnaround of a few days. We applied it to a chemorefractory metastatic case of the extremely rare urachal carcinoma. Quantitative comparison of lung metastases and surrounding tissue revealed several significantly upregulated proteins, among them lysine-specific histone demethylase 1 (LSD1/KDM1A). LSD1 is an epigenetic regulator and the target of active development efforts in oncology. Thus, clinical cancer proteomics can rapidly and efficiently identify actionable therapeutic options. While currently described for a single case study, we envision that it can be applied broadly to other patients in a similar condition. |
DOI: | doi:10.1002/1878-0261.12326 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1002/1878-0261.12326 |
| Volltext: https://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1878-0261.12326 |
| DOI: https://doi.org/10.1002/1878-0261.12326 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | case study |
| clinical proteomics |
| epigenetics |
| mass spectrometry |
| urachal carcinoma |
K10plus-PPN: | 1663081689 |
Verknüpfungen: | → Zeitschrift |
Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient / Doll, Sophia [VerfasserIn]; 14 June 2018 (Online-Ressource)